1094 related articles for article (PubMed ID: 22986158)
21. Leukotriene D4 receptor antagonist montelukast alleviates protamine sulphate-induced changes in rat urinary bladder.
Çetinel S; Çanıllıoğlu YE; Çikler E; Sener G; Ercan F
BJU Int; 2011 Apr; 107(8):1320-5. PubMed ID: 20735385
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of sepsis-induced pancreatic injury by leukotriene receptor antagonism via modulation of oxidative injury, and downregulation of inflammatory markers in experimental rats.
Hagar HH; Alhazmi SM; Arafah M; Bayoumy NM
Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):3425-3435. PubMed ID: 37962585
[TBL] [Abstract][Full Text] [Related]
23. Beneficial effects of montelukast against cisplatin-induced acute renal damage in rats.
Beytur A; Köse E; Sarihan ME; Sapmaz HI; Dogan Z; Cetin A; Vardi N; Turkoz Y; Ekinci N
Ren Fail; 2012; 34(3):343-9. PubMed ID: 22260262
[TBL] [Abstract][Full Text] [Related]
24. Montelukast attenuates neuropathic pain through inhibiting p38 mitogen-activated protein kinase and nuclear factor-kappa B in a rat model of chronic constriction injury.
Zhou C; Shi X; Huang H; Zhu Y; Wu Y
Anesth Analg; 2014 May; 118(5):1090-6. PubMed ID: 24686047
[TBL] [Abstract][Full Text] [Related]
25. Effects of prostaglandin E1, melatonin, and oxytetracycline on lipid peroxidation, antioxidant defense system, paraoxonase (PON1) activities, and homocysteine levels in an animal model of spinal cord injury.
Topsakal C; Kilic N; Ozveren F; Akdemir I; Kaplan M; Tiftikci M; Gursu F
Spine (Phila Pa 1976); 2003 Aug; 28(15):1643-52. PubMed ID: 12897486
[TBL] [Abstract][Full Text] [Related]
26. Melatonin protects against endosulfan-induced oxidative tissue damage in rats.
Omurtag GZ; Tozan A; Sehirli AO; Sener G
J Pineal Res; 2008 May; 44(4):432-8. PubMed ID: 18205731
[TBL] [Abstract][Full Text] [Related]
27. Protective effects of melatonin against spinal cord injury induced oxidative damage in rat kidney: A morphological and biochemical study.
Akakin D; Kiran D; Ozkan N; Erşahin M; Ozdemir-Kumral ZN; Yeğen B; Sener G
Acta Histochem; 2013 Oct; 115(8):827-34. PubMed ID: 23725902
[TBL] [Abstract][Full Text] [Related]
28. Cysteinyl-leukotriene receptor antagonist montelukast decreases blood-brain barrier permeability but does not prevent oedema formation in traumatic brain injury.
Biber N; Toklu HZ; Solakoglu S; Gultomruk M; Hakan T; Berkman Z; Dulger FG
Brain Inj; 2009 Jun; 23(6):577-84. PubMed ID: 19484631
[TBL] [Abstract][Full Text] [Related]
29. Protective effects of taurine against nicotine-induced oxidative damage of rat urinary bladder and kidney.
Sener G; Sehirli O; Ipçi Y; Cetinel S; Cikler E; Gedik N; Alican I
Pharmacology; 2005 Apr; 74(1):37-44. PubMed ID: 15640613
[TBL] [Abstract][Full Text] [Related]
30. Ghrelin improves burn-induced multiple organ injury by depressing neutrophil infiltration and the release of pro-inflammatory cytokines.
Sehirli O; Sener E; Sener G; Cetinel S; Erzik C; Yeğen BC
Peptides; 2008 Jul; 29(7):1231-40. PubMed ID: 18395937
[TBL] [Abstract][Full Text] [Related]
31. Methothrexate attenuates early neutrophil infiltration and the associated lipid peroxidation in the injured spinal cord but does not induce neurotoxicity in the uninjured spinal cord in rats.
Sanli AM; Serbes G; Sargon MF; Calişkan M; Kilinç K; Bulut H; Sekerci Z
Acta Neurochir (Wien); 2012 Jun; 154(6):1045-54. PubMed ID: 22354719
[TBL] [Abstract][Full Text] [Related]
32. Functional and structural changes of the urinary bladder following spinal cord injury; treatment with alpha lipoic acid.
Ekiz A; Özdemir-Kumral ZN; Erşahin M; Tuğtepe H; Öğünç AV; Akakın D; Kıran D; Özsavcı D; Biber N; Hakan T; Yeğen BÇ; Şener G; Toklu HZ
Neurourol Urodyn; 2017 Apr; 36(4):1061-1068. PubMed ID: 27490041
[TBL] [Abstract][Full Text] [Related]
33. Ameliorative potential of montelukast on ischemia-reperfusion injury induced vasculitic neuropathic pain in rat.
Muthuraman A; Ramesh M; Sood S
Life Sci; 2012 May; 90(19-20):755-62. PubMed ID: 22483690
[TBL] [Abstract][Full Text] [Related]
34. Lycopene inhibits caspase-3 activity and reduces oxidative organ damage in a rat model of thermal injury.
Cevik O; Oba R; Macit C; Cetinel S; Kaya OT; Sener E; Sener G
Burns; 2012 Sep; 38(6):861-71. PubMed ID: 22356815
[TBL] [Abstract][Full Text] [Related]
35. Montelukast prevents ischaemia/reperfusion-induced ovarian damage in rats.
Akdemir A; Erbaş O; Ergenoğlu M; Ozgür Yeniel A; Oltulu F; Yavaşoğlu A; Taskiran D
Eur J Obstet Gynecol Reprod Biol; 2014 Feb; 173():71-6. PubMed ID: 24360058
[TBL] [Abstract][Full Text] [Related]
36. Protective effects of edaravone on experimental spinal cord injury in rats.
Ozgiray E; Serarslan Y; Oztürk OH; Altaş M; Aras M; Söğüt S; Yurtseven T; Oran I; Zileli M
Pediatr Neurosurg; 2011; 47(4):254-60. PubMed ID: 22310070
[TBL] [Abstract][Full Text] [Related]
37. Myeloperoxidase exacerbates secondary injury by generating highly reactive oxygen species and mediating neutrophil recruitment in experimental spinal cord injury.
Kubota K; Saiwai H; Kumamaru H; Maeda T; Ohkawa Y; Aratani Y; Nagano T; Iwamoto Y; Okada S
Spine (Phila Pa 1976); 2012 Jul; 37(16):1363-9. PubMed ID: 22322369
[TBL] [Abstract][Full Text] [Related]
38. Carvedilol promotes neurological function, reduces bone loss and attenuates cell damage after acute spinal cord injury in rats.
Liu D; Huang Y; Li B; Jia C; Liang F; Fu Q
Clin Exp Pharmacol Physiol; 2015 Feb; 42(2):202-12. PubMed ID: 25424914
[TBL] [Abstract][Full Text] [Related]
39. Medroxyprogesterone acetate, enoxaparin and pentoxyfylline cause alterations in lipid peroxidation, paraoxonase (PON1) activities and homocysteine levels in the acute oxidative stress in an experimental model of spinal cord injury.
Topsakal C; Kilic N; Erol FS; Kaplan M; Akdemir I; Tiftikci M; Gursu F
Acta Neurochir (Wien); 2002 Oct; 144(10):1021-31; discussion 1031. PubMed ID: 12382130
[TBL] [Abstract][Full Text] [Related]
40. Melatonin and tadalafil treatment improves erectile dysfunction after spinal cord injury in rats.
Tavukçu HH; Sener TE; Tinay I; Akbal C; Erşahin M; Cevik O; Cadirci S; Reiter RJ; Sener G
Clin Exp Pharmacol Physiol; 2014 Apr; 41(4):309-16. PubMed ID: 24552354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
